| Christophe Hotermans |
Christophe Hotermans currently works at Alexion Pharmaceuticals, Inc., as Senior Vice President & Head-Medical Affairs from 2021. |
| Patryk Mikucki |
Patryk Mikucki is currently working as the Vice President of Clinical Research at Alexion Pharmaceuticals, Inc. and as the Vice President at Astrazeneca Pharma Poland SP zoo. He is also a Member of the Supervisory Board at Scope Fluidics SA. Dr. Mikucki has an MBA from the University of Illinois and a doctorate from the University of Life Sciences in Lublin. |
| Morgan Sanford |
Morgan Sanford is currently working as the Chief of Staff at Alexion Pharmaceuticals, Inc. Prior to this, they completed an undergraduate degree at Hamilton College (New York) and an MBA at The Leonard N Stern School of Business. |
| Sean Christie |
Sean Christie currently works at Alexion Pharmaceuticals, Inc., as Chief Financial & Administration Officer from 2021. |
| Seng H. Cheng |
Seng H. Cheng currently works at Alexion Pharmaceuticals, Inc., as Senior VP, Head-Research & Product Development from 2023. |
| Ruth Diazaraque |
Ruth Diazaraque currently works at Alexion Pharmaceuticals, Inc., as Vice President-Research & Development from 2023. |
| Marc Pierre Jean Dunoyer |
Marc Pierre Jean Dunoyer is currently the Chief Executive Officer at Alexion Pharmaceuticals, Inc. He is also the Chairman at AstraZeneca KK. In addition, he holds director positions at AstraZeneca UK Ltd., AstraZeneca Intermediate Holdings Ltd., Acerta Pharma BV, Orchard Therapeutics (Europe) Ltd., and Cellectis SA. Previously, he served as the Chief Strategy Officer at AstraZeneca PLC. Prior to his current roles, he was the Chairman at GlaxoSmithKline KK and Orchard Therapeutics Plc. He also held positions as the President-Asia Pacific at Hoechst Marion Roussel SA and the Global Head-Rare Diseases Unit at GSK Plc. Mr. Dunoyer has an MBA from Hautes Etudes Commerciales and a graduate degree from Université de Paris IV Paris-Sorbonne. |
